In August 2024, Medicilon USA Corp (Medicilon) officially commenced operations at its second R&D center in Massachusetts, USA. Research at the new facility will focus on animal models for PK/PD and toxicology studies. This milestone heralds Medicilon's continued global business expansion. Medicilon aims to enhanc…
Axsendo Clinical Research (ACR), a national clinical research site network, is excited to announce the opening of its newest location in Phoenix, Arizona. Complementing ACR's existing state-of-the-art facility in Houston, TX, this expansion into the Southwest corridor will increase access to research for Phoenix's div…
Research highlights significant benefits of employing individuals with autism spectrum disorder (ASD), including an 89% higher retention rate, a 72% increase in employee productivity, and a 28% increase in profitability. By becoming an autism inclusive employer, companies can access a large, untapped pool of potentia…
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, today hosted a celebration for the opening of its microbial fermentation manufacturing facility in Billingham. This new facility triples exis…
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod brand of products, hosted a grand opening celebration at its new manufacturing facility in Johor Bahru, Malaysia. “Insulet’s remarkable growth is driven by our market-leading Omnipod 5, the first and only tubeless automated i…
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced an agreement with Taipei-based Prisma Biotech to broaden Parse’s reach in Taiwan and across Asia-Pacific. “Biotech, pharma, and academic researchers across Asia are boosting demand for Parse’s Evercode single …
Cipla Limited announced that its wholly-owned subsidiary in United Kingdom, Cipla (EU) Limited will invest an additional EUR 3 million in Ethris GmbH (“Ethris”), a global leader in delivering mRNAs directly to the respiratory system. This additional investment through a convertible loan will accelerate Cipla’s partici…
A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic discovery capability under the leadership of Therapeutic Innovation Australia (TIA). The funding from the Queensland Government’s Department of Environment, Science and Inn…
In a significant step towards augmenting India's scientific research capabilities, the Indian Institute of Technology Kanpur (IITK) inaugurated its National Cryogenic-Electron Microscopy (Cryo-EM) facility. The facility, established with support from the Science and Engineering Research Board (SERB), now integrated w…
Merck, a leading science and technology company, announces an investment of € 62 million at its Darmstadt headquarters in a new quality control building for its Life Science business. The facility will bring together approximately 135 employees across several departments into one collaborative state-of-the-art space. …
Page 36 of 61